A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients

Clinical trial NCT02879617 · COMPLETED

Trial details

NCT number: NCT02879617
Sponsor: Academic Thoracic Oncology Medical Investigators Consortium
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer NSCLC

Start date: 2017-04-04
Primary completion: 2022-06-04
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.